Tilray Inc (Class 2) (TLRY)

$8.10USD

+$8.10 (+810.00%)

today (15 min delay)

About TLRY

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada.

CEO

Brendan Kennedy, MBA

Headquarters

Canada

Employees

1.65K

Revenue (TTM)

196M

Gross Profit

19.16%

Earnings

-364.64%

Cash

$174M

Debt

$509M

TLRY related news

    Popular on Wealthsimple

      Trade app demonstration video

      Commission-free stock trading

      Wealthsimple Trade lets you buy and sell thousands of stocks and exchange-traded funds (ETFs) on major Canadian and U.S. exchanges.

      Wealthsimple Trade lets you buy and sell thousands of stocks and exchange-traded funds (ETFs) on major Canadian and U.S. exchanges.

      • Unlimited trades, all commission-free

      • No account minimum means you can get started with as little as $1

      • No jargon, and no paperwork

      • Search and track stocks easily with your watchlist

      • Buy and sell stocks with just a few taps

      Clock

      Start trading in 5 minutes

      1. Download the Wealthsimple Trade mobile app
      2. Securely connect your bank account to deposit funds
      3. Buy and sell stocks with $0 commission fees

      By clicking "Get started", you agree to Wealthsimple's Terms of Use and Privacy Policy.